Literature DB >> 23639026

Expanding functions of intracellular resident mono-ADP-ribosylation in cell physiology.

Karla L H Feijs1, Patricia Verheugd, Bernhard Lüscher.   

Abstract

Poly-ADP-ribosylation functions in diverse signaling pathways, such as Wnt signaling and DNA damage repair, where its role is relatively well characterized. Contrarily, mono-ADP-ribosylation by for example ARTD10/PARP10 is much less understood. Recent developments hint at the involvement of mono-ADP-ribosylation in transcriptional regulation, the unfolded protein response, DNA repair, insulin secretion and immunity. Additionally, macrodomain-containing hydrolases, MacroD1, MacroD2 and C6orf130/TARG1, have been identified that make mono-ADP-ribosylation reversible. Complicating further progress is the lack of tools such as mono-ADP-ribose-specific antibodies. The currently known functions of mono-ADP-ribosylation are summarized here, as well as the available tools such as mass spectrometry to study this modification in vitro and in cells.
© 2013 FEBS.

Entities:  

Keywords:  ADP-ribosylation; ARTD/PARP family; macrodomain-containing protein; mass spectrometry; stress response and inflammation

Mesh:

Substances:

Year:  2013        PMID: 23639026     DOI: 10.1111/febs.12315

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  34 in total

Review 1.  Histones: at the crossroads of peptide and protein chemistry.

Authors:  Manuel M Müller; Tom W Muir
Journal:  Chem Rev       Date:  2014-10-20       Impact factor: 60.622

Review 2.  The intrinsic disorder alphabet. III. Dual personality of serine.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2015-03-17

3.  PARP10 deficiency manifests by severe developmental delay and DNA repair defect.

Authors:  Maher Awni Shahrour; Claudia M Nicolae; Simon Edvardson; Motee Ashhab; Adri M Galvan; Daniel Constantin; Bassam Abu-Libdeh; George-Lucian Moldovan; Orly Elpeleg
Journal:  Neurogenetics       Date:  2016-09-13       Impact factor: 2.660

Review 4.  New PARP targets for cancer therapy.

Authors:  Sejal Vyas; Paul Chang
Journal:  Nat Rev Cancer       Date:  2014-06-05       Impact factor: 60.716

5.  A macrodomain-linked immunosorbent assay (MLISA) for mono-ADP-ribosyltransferases.

Authors:  Jingwen Chen; Albert T Lam; Yong Zhang
Journal:  Anal Biochem       Date:  2017-12-13       Impact factor: 3.365

6.  Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.

Authors:  Ian Carter-O'Connell; Michael S Cohen
Journal:  Curr Protoc Chem Biol       Date:  2015-06-01

7.  The ADP-ribosyltransferase PARP10/ARTD10 interacts with proliferating cell nuclear antigen (PCNA) and is required for DNA damage tolerance.

Authors:  Claudia M Nicolae; Erin R Aho; Alexander H S Vlahos; Katherine N Choe; Subhajyoti De; Georgios I Karras; George-Lucian Moldovan
Journal:  J Biol Chem       Date:  2014-04-02       Impact factor: 5.157

8.  Processing of protein ADP-ribosylation by Nudix hydrolases.

Authors:  Luca Palazzo; Benjamin Thomas; Ann-Sofie Jemth; Thomas Colby; Orsolya Leidecker; Karla L H Feijs; Roko Zaja; Olga Loseva; Jordi Carreras Puigvert; Ivan Matic; Thomas Helleday; Ivan Ahel
Journal:  Biochem J       Date:  2015-06-01       Impact factor: 3.857

Review 9.  PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis.

Authors:  Weronika Wasyluk; Agnieszka Zwolak
Journal:  J Inflamm Res       Date:  2021-05-06

10.  Association of MACROD2 gene variants with obesity and physical activity in a Korean population.

Authors:  Hye-Rim Kim; Hyun-Seok Jin; Yong-Bin Eom
Journal:  Mol Genet Genomic Med       Date:  2021-02-24       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.